Phibro Animal Health (NASDAQ:PAHC) Releases FY 2025 Earnings Guidance

Phibro Animal Health (NASDAQ:PAHC) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 1.220-1.370 for the period, compared to the consensus estimate of 1.380. The company issued revenue guidance of $1.0 billion-$1.1 billion, compared to the consensus revenue estimate of $1.1 billion.

Phibro Animal Health Stock Down 2.2 %

PAHC opened at $21.00 on Friday. Phibro Animal Health has a twelve month low of $9.40 and a twelve month high of $22.31. The firm has a market cap of $850.56 million, a price-to-earnings ratio of 65.63, a PEG ratio of 4.71 and a beta of 0.57. The firm’s 50-day simple moving average is $18.25 and its 200-day simple moving average is $16.00. The company has a debt-to-equity ratio of 1.69, a quick ratio of 1.67 and a current ratio of 3.16.

Phibro Animal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Stockholders of record on Wednesday, September 4th will be issued a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 2.29%. The ex-dividend date of this dividend is Wednesday, September 4th. Phibro Animal Health’s payout ratio is 150.00%.

Analyst Upgrades and Downgrades

PAHC has been the subject of a number of recent analyst reports. Barclays raised their price target on Phibro Animal Health from $10.00 to $13.00 and gave the company an underweight rating in a report on Friday, May 10th. Bank of America raised their price target on Phibro Animal Health from $13.00 to $15.00 and gave the company an underperform rating in a report on Friday. Three equities research analysts have rated the stock with a sell rating, one has issued a hold rating and one has given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of Hold and an average price target of $13.25.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.